Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in mCRC (REGARD)
NCT01853319Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of regorafenib in metastatic colorectal cancer (mCRC), sponsored by Bayer. Started Jul 2013; status: completed.
02
Drugs
regorafenib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01853319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853319.